Ophthalmologists who treat children with a diagnosis of vision loss can help with the near-term adjustment and long-term pursuit of goals by providing information about rehabilitation programs, support groups, and other resources.
Ophthalmologists who treat children with a diagnosis of vision loss can help with the near-term adjustment and long-term pursuit of goals by providing information about rehabilitation programs, support groups, and other resources.
In pediatric cataract surgery, use of an ocular sealant not only also helps prevent wound leakage but also provides extra protection against eye rubbing and wound manipulation.
Long-term cone functional rescue was achieved in dogs with achromatopsia AAV vectors containing codon-optimized human CNGB3 and an improved promoter, which may be a stepping stone to treating achromatopsia in humans.
Most patients with acute nonarteritic central retinal artery occlusion have a cardiovascular risk profile, and a comprehensive medical evaluation can uncover more risk factors.
The rate of postoperative cystoid macular edema was lower in a recent study of nearly 1,000 cataract surgery patients at two sites using intravitreal transzonular antibiotic and steroid prophylaxis than in previous studies with topical administration.
An endoscope can improve outcomes in cases in which the view through the traditional operating microscope is known to be compromised preoperatively, and is a good backup if a problem makes visualization difficult intraoperatively.
Evidence suggests that nitric oxide can modify both mechanical and vascular events in primary open-angle glaucoma pathogenesis.
Joseph Panarelli, MD, and Arsham Sheybani, MD, discuss the Primary Trabeculectomy for Advanced Glaucoma: Pragmatic Multicentre Randomized Controlled Trial, or TAGS trial, and how this can apply to real world situation. This multicenter randomized controlled trial evaluated whether primary trabeculectomy or primary medical treatment leads to improved outcomes in terms of quality of life, clinical effectiveness, and safety.
Anti-integrin therapy is a promising new approach in the treatment of vitreoretinal disease. The first drug in this class, Allegro Ophthalmics’ Luminate, is in Phase 2 clinical trials for several indications, including wet age-related macular degeneration, diabetic macular edema, non-proliferative diabetic retinopathy, and vitreomacular traction.
Cynthia Matossian, MD, shares her thoughts on the premium patient "experience" or "journey," emphasizing the outcomes of patient experiences.
Understanding of keratoconus and the resulting dramatic changes in management in recent years have given rise to treatment paradigms that would have been unrecognizable to ophthalmologists a generation ago. The new landscape features a wider range of treatment options, better diagnostic and monitoring tools, and better understanding of the underlying pathology of the disease.
The rate of postoperative cystoid macular edema was lower in a recent study of nearly 1,000 cataract surgery patients at two sites using intravitreal transzonular antibiotic and steroid prophylaxis than in previous studies with topical administration.
The glasses prescribing patterns of a pediatric ophthalmology group differed from the guidelines issued by the American Academy of Ophthalmology for infants less than age 1 year but were similar for children age 1 to 3 years, a study found. The study also demonstrated the efficacy of using electronic medical records for assessing physician decision-making.
Ophthalmologists discuss the importance of routine contrast sensitivity and glare testing in cataract-age adults and specifically the use of a platform that includes a real-world driver’s scene.
: Highlights are presented from what is believed to be the first head-to-head comparison of one, two, and three stents inserted as a stand-alone procedure.
If you own a small business (such as a medical practice), many retirement plan alternatives are available to assist you and your eligible employees with retirement planning. To make an informed decision on which plan is right for your practice, review the differences carefully before choosing.
Ophthalmology Times is pleased to announce Amy Patel, MD, of Gavin Herbert Eye Institute, UC Irvine Health, Irvine, CA, as the winner of its 2015 Resident Writer’s Award Program, sponsored by Allergan. Dr. Patel’s winning entry is featured here.
A 65-year-old male with a history of congenital cataracts, bilateral cataract extraction and secondary placement of anterior chamber intraocular lenses with subsequent development of glaucoma, cicatricial conjunctivitis, dry eye and limbal stem cell deficiency presented with left eye pain and decreased vision.
Ophthalmologists all know how to safely watch an eclipse, but how will ophthalmologists around the country be participating in and observing the event?
According to the 2006 U.S. Census more than 112 million Americans are over the age of 45 and will most likely need reading glasses. This provides a unique business opportunity for dispensaries. As a generation who loves quality, style, and design, it makes sense that our new wave of shoppers will want the same attributes from their reading glasses. If we take the time to dress well, selecting just the right necktie, jewelry, or accessory, we are not going to want to pull out a bland pair of reading glasses in a meeting. Our love of brands and fashion will extend to our readers.
In 2001, Tim Steinemann, MD, and his residents treated a 14-year-old girl with a contact-lens related Pseudomonas corneal ulcer. The contact lenses were decorative and were purchased over-the-counter (OTC). Dr. Steinemann and his residents went about telling their story. The AAO worked aggressively with other organizations to oppose new FDA rules that allowed OTC sale of contacts. After vigorous lobbying by all the groups involved, the bill was signed into law in November 2005 and enacted in January 2006.
A 38-year-old Hispanic male presented to the Bascom Palmer Eye Institute clinic complaining of poor vision since childhood. The patient stated that his vision had been poor since he was a child and wanted to know if glasses could help his vision. He denied any ocular pain, redness, discharge, flashing lights, floaters, or diplopia.
An accommodating IOL (NuLens, NuLens Ltd.) is one of the most exciting IOL technologies under development and research. This lens differs from single-optic and dual-optic accommodating IOL designs in that it changes its power during accommodative effort not by a movement in IOL optic position, but by a change in the radius of curvature of the optic surface.
A 38-year-old Hispanic male presented to the Bascom Palmer Eye Institute clinic complaining of poor vision since childhood. The patient stated that his vision had been poor since he was a child and wanted to know if glasses could help his vision. He denied any ocular pain, redness, discharge, flashing lights, floaters, or diplopia.
Compensation techniques in swept-source optical coherence tomography angiography improve accuracy by correcting signal loss from drusen and other artifacts
A 38-year-old Hispanic male presented to the Bascom Palmer Eye Institute clinic complaining of poor vision since childhood. The patient stated that his vision had been poor since he was a child and wanted to know if glasses could help his vision. He denied any ocular pain, redness, discharge, flashing lights, floaters, or diplopia.
'Managing Your ASC' is a new, ongoing forum for addressing your questions related to managing your present or future ASC. Our question and answer format will provide you with real-world solutions to concerns